pantoprazole has been researched along with Esophageal Varices in 6 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boo, GB | 1 |
Oh, JC | 1 |
Lee, BJ | 1 |
Lee, DM | 1 |
Kim, YD | 1 |
Park, CG | 1 |
Kim, MW | 1 |
Alaniz, C | 1 |
Mohammad, RA | 1 |
Welage, LS | 1 |
Miranda, WR | 1 |
Smith, JM | 1 |
Burton, MC | 1 |
Lo, GH | 1 |
Perng, DS | 1 |
Chang, CY | 1 |
Tai, CM | 1 |
Wang, HM | 1 |
Lin, HC | 1 |
Shaheen, NJ | 1 |
Stuart, E | 1 |
Schmitz, SM | 1 |
Mitchell, KL | 1 |
Fried, MW | 1 |
Zacks, S | 1 |
Russo, MW | 1 |
Galanko, J | 1 |
Shrestha, R | 1 |
Al-Sabah, S | 1 |
Barkun, AN | 1 |
Herba, K | 1 |
Adam, V | 1 |
Fallone, C | 1 |
Mayrand, S | 1 |
Pomier-Layrargues, G | 1 |
Kennedy, W | 1 |
Bardou, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Controlled Trial of Ligation Plus Vasoconstrictor vs.Ligation Plus Proton Pump Inhibitor in the Control of Acute Esophageal Variceal Bleeding[NCT01112852] | Phase 4 | 118 participants (Actual) | Interventional | 2006-12-31 | Completed | ||
Comparative Effectiveness Research: Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails to Treat the Patients With Acute Variceal Bleeding[NCT02311608] | 1,320 participants (Anticipated) | Observational | 2014-02-28 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 trials available for pantoprazole and Esophageal Varices
Article | Year |
---|---|
[The effect of proton pump inhibitor on healing of post-esophageal variceal ligation ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Esophageal and Gastric Varices; Esophago | 2008 |
Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Combined Modality Therapy; Esophageal and Gast | 2013 |
Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Combined Modality Therapy; Esophageal and Gast | 2013 |
Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Combined Modality Therapy; Esophageal and Gast | 2013 |
Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Combined Modality Therapy; Esophageal and Gast | 2013 |
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Double-Blind Method; Esophageal and Gastric | 2005 |
3 other studies available for pantoprazole and Esophageal Varices
Article | Year |
---|---|
Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhage.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Blood Transfusion; Cohort Studies; Drug | 2009 |
33-year-old woman with epigastric pain and hematemesis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Diagnosis, Differential; Eosinoph | 2012 |
Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Canada; Cost-Benefit Analysis; Decision Trees; Dose-Respons | 2008 |